Background: To date there exist no internationally recognised Good Manufacturing Practices
(GMP) that clearly outline universally accepted standards for manufacturing highly active or …

Background: The manufacture of medicinal products for human use in the European
Economic Area is governed by European Directives and Regulations stipulating the relevant …

In every country, a manufacturer of medicinal products for either human or veterinary use is
required to operate in compliance with local legislation. In all EU Member States, legislation …

The term GMP was introduced to regulate manufacturing and packaging operations in the
pharmaceutical company. Until the mid-1960s, operating procedures for the manufacture of …

Objectives: The objectives of this study were to analyze the current structure of the Turkish
pharmaceuticals market to explain the latest developments and to offer some insight into the …

Background: Approximately 91% of drugs are imported, some of which are quite expensive
and unaffordable for the majority of the population. The process of drug development, ie the …

Availability of medicinal products is a crucial issue of any healthcare system. Pharmaceutical
industry, which is a global conglomerate of profit-driven private enterprises, needs much …

As a fact of drugs availability of the drugs in the pharmaceutical assistance of the population,
the range of pharmaceutical products authorized to be used in therapeutics represents the …

Introduction and objective The regulation of pharmacy preparations, especially for standards
for quality assurance and safety, is not harmonised across Europe and falls under the …

The quality of pharmaceutical preparations is the result of the planning and implementation
of the manufacturing process. The Good Manufacturing Practice (GMP) principles and …